Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Matteucci

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|November 30, 2020
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of <sup>225</sup>Ac-PSMA (Prostate-Specific Membrane Antigen)Maria Luisa Belli, Anna Sarnelli, Emilio Mezzenga, et al.
Neurology|July 31, 2024
<sup>18F</sup>Flutemetamol-PET Aided Classification of Cerebral Amyloid Angiopathy: A Multicenter StudyMichele Romoli, Giulia Marinoni, Luca Tagliabue, et al.
Medicinal Research Reviews|May 29, 2024
Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligandsGianfabio Giorgioni, Alessandro Bonifazi, Luca Botticelli, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
JCO Precision Oncology|February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA AnalysisVincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2019
Ten-year experience of the multidisciplinary Osteoncology CenterAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Journal of Visualized Experiments : Jove|May 12, 2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image MethodsMaria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|November 30, 2020
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of <sup>225</sup>Ac-PSMA (Prostate-Specific Membrane Antigen)Maria Luisa Belli, Anna Sarnelli, Emilio Mezzenga, et al.
Neurology|July 31, 2024
<sup>18F</sup>Flutemetamol-PET Aided Classification of Cerebral Amyloid Angiopathy: A Multicenter StudyMichele Romoli, Giulia Marinoni, Luca Tagliabue, et al.
Medicinal Research Reviews|May 29, 2024
Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligandsGianfabio Giorgioni, Alessandro Bonifazi, Luca Botticelli, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
JCO Precision Oncology|February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA AnalysisVincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2019
Ten-year experience of the multidisciplinary Osteoncology CenterAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Journal of Visualized Experiments : Jove|May 12, 2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image MethodsMaria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, et al.
Pageof 8